China Regenerative Medicine International Limited Financial Overview
China Regenerative Medicine International Limited's market cap is currently HK$231.23M. The company's EPS TTM is HK$0.015; its P/E ratio is 41.76; China Regenerative Medicine International Limited is scheduled to report earnings on August 22, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in HKD
China Regenerative Medicine International Limited Earnings and Revenue History
